Tokyo, Japan

Arnone Nithichanon

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Infectious Diseases. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnone Nithichanon. Retrieved from https://idiyas.com/inventor/arnone-nithichanon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnone Nithichanon: Innovator in Viral Research

Introduction

Arnone Nithichanon is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of infectious diseases, particularly through his innovative research and development of antibodies.

Latest Patents

Nithichanon holds a patent for a "Flavivirus Cross Neutralizing Antibody and Pharmaceutical Composition." This patent represents a crucial advancement in the fight against flavivirus-related diseases, showcasing his expertise and dedication to public health.

Career Highlights

He is currently affiliated with the National Institute of Infectious Diseases, where he conducts vital research aimed at understanding and combating infectious diseases. His work has garnered attention for its potential impact on global health.

Collaborations

Nithichanon collaborates with fellow researcher Takayuki Matsumura, enhancing the scope and depth of their research efforts. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Arnone Nithichanon's contributions to viral research and his innovative patent highlight his role as a key figure in the field of infectious diseases. His work continues to inspire advancements in medical science and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…